Visible cracks, crumbling paint and spreading black mold now mar the historic walls of the Duke of York’s 30-room mansion. The Royal Lodge, on 98 acres in Windsor Great Park, has been in royal ...

So will his silver oil lamps, his French marble and bronze mantel clock, and most of the other contents of his elegant 290-year-old Mount Vernon mansion on the Potomac River. On Nov. 1 ...

Shares of Eli Lilly and Co. slumped toward their biggest selloff in more than three years on Wednesday, after the drugmaker reported third-quarter results that missed expectations, due to big ...

It was a blast from the past for Westlife's Brian McFadden as he showed up to the Billie Barry School's 60th anniversary ball ...

Eli Lilly shares slid after the drugmaker reported disappointing quarterly results, with sales of its popular diabetes and anti-obesity drugs lower than expected. Lilly said inventory decreases by ...

Mansion Global is the premier digital destination connecting the world's most affluent real estate buyers with prestigious properties around the globe through relevant, timely listings and ...

Eli Lilly has seen massive returns this year and is one of the most expensive healthcare stocks in the world. Its new products have strong growth prospects, but their potential may still be ...

If you're not a LEGO Insider, you can sign up for free. LEGO insiders who purchase the set anytime from November 1–7 will receive a LEGO Marvel Cerebro set as a free gift, which includes the ...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

Yet, Eli Lilly's GLP-1 medications are helping it compete with the leader. Plus, Lilly also has several other promising catalysts to consider. These are two of healthcare's biggest darlings right ...

Nico Chen has given his Buy rating due to a combination of factors including Eli Lilly’s strong revenue growth and the potential expansion of its diabetes medication Mounjaro. Chen recognizes ...